Seattle WA 1型糖尿病临床试验
19项针对 1型糖尿病的研究正在 Seattle及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes
招募中
- Seattle Children's, Seattle
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
招募中3 期
- Benaroya Research Institute at Virginia Mason- Site Number : 8400038, Seattle
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
招募中1/2 期
- Benaroya Research Institute, Seattle
- University of Washington Diabetes Institute, Seattle
A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
招募中1/2 期
- Seattle Children's Hospital, Seattle
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
招募中2 期
- Benaroya Research Institute at Virginia Mason, Seattle
Type 1 Diabetes Extension Study
招募中观察性研究
- Benaroya Research Institute, Seattle
METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
招募中2 期
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle
Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
招募中2 期
- Benaroya Research Institute, Seattle
Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
招募中2 期
- Benaroya Research Institute, Seattle
Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery
招募中
- University of Washington, Seattle
Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
招募中2 期
- University of Washington, Seattle
Kidney Precision Medicine Project
招募中观察性研究
- University of Washington, Seattle
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
招募中3 期
- University of Washington, Seattle
Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes
招募中3 期
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle
Achieving Health in Emerging Adults With Diabetes (AHEAD) Program: A Clinical Trial Designed to Understand if Participation in a Clinical Program Developed Specifically to Support Emerging Adults With Type 1 Diabetes Leads to Improved Diabetes Outcomes.
招募中
- Seattle Children's, Seattle
EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)
招募中观察性研究
- Benaroya Research Institute, Seattle
InvesT1D: Promoting Adolescent Investment in Diabetes Care
招募中
- Seattle Children's, Seattle
TrialNet Pathway to Prevention of T1D
招募中观察性研究欢迎健康志愿者
- Benaroya Research Institute, Seattle
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
招募中1 期
- Seattle Children's Hospital, Seattle
其他城市的 1型糖尿病试验
- Aurora, CO26 项研究
- Boston, MA21 项研究
- San Francisco, CA16 项研究
- Chicago, IL16 项研究
- New Haven, CT16 项研究
- New York City, NY15 项研究
- Indianapolis, IN14 项研究
- Miami, FL14 项研究
- Atlanta, GA13 项研究
- Gainesville, FL13 项研究
- Philadelphia, PA11 项研究
- Durham, NC11 项研究
Seattle的其他研究
- 非小细胞肺癌55 项研究
- 癌症（所有类型）48 项研究
- 前列腺癌45 项研究
- 急性髓系白血病40 项研究
- 转移性癌症39 项研究
- 乳腺癌37 项研究
- 结直肠癌35 项研究
- 肺癌34 项研究
- 卵巢癌29 项研究
- 胰腺癌22 项研究
- 多发性骨髓瘤22 项研究
- 急性淋巴细胞白血病22 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年11月15日。每项研究自行设定入选标准，由研究团队决定谁能参与。